Connect Biopharma Holdings (CNTB) Tax Provisions (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Tax Provisions of $48000.0 for Q1 2026, up 77.78% sequentially from $27000.0 in Q4 2025, and down 11.11% YoY from $54000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Tax Provisions (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Tax Provisions for 3 years, with the latest figure at $48000.0 in Q1 2026.
- Quarterly Tax Provisions fell 11.11% year-over-year to $48000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $191000.0 (down 22.67% YoY) and the FY2025 annual result came in at $197000.0, down 11.66% from the prior year.
- Tax Provisions rose to $48000.0 in Q1 2026 per CNTB's latest filing, from $27000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $106000.0 in Q4 2024 and troughed at $27000.0 in Q4 2025.
- A 3-year average of $52000.0 and a median of $54000.0 in 2025 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 83.33% in 2025, down 74.53% in 2025.
- Over 3 years, Tax Provisions stood at $106000.0 in 2024, then slumped by 74.53% to $27000.0 in 2025, then jumped by 77.78% to $48000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $48000.0, $27000.0, and $61000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60,000.00 |
| Mar 31, 2026 | 48,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 30,000.00 |